NASDAQ
LNSR

LENSAR Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

LENSAR Inc Stock Price

Vitals

Today's Low:
$3.01
Today's High:
$3.17
Open Price:
$3.17
52W Low:
$1.9
52W High:
$6.19
Prev. Close:
$3.05
Volume:
1622

Company Statistics

Market Cap.:
$38.01 million
Book Value:
2.919
Revenue TTM:
$38.24 million
Operating Margin TTM:
-36.41%
Gross Profit TTM:
$19.96 million
Profit Margin:
-51%
Return on Assets TTM:
-13.4%
Return on Equity TTM:
-42.71%

Company Profile

LENSAR Inc had its IPO on 2020-10-02 under the ticker symbol LNSR.

The company operates in the Healthcare sector and Medical Devices industry. LENSAR Inc has a staff strength of 110 employees.

Stock update

Shares of LENSAR Inc opened at $3.17 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.01 - $3.17, and closed at $3.03.

This is a -0.66% slip from the previous day's closing price.

A total volume of 1,622 shares were traded at the close of the day’s session.

In the last one week, shares of LENSAR Inc have slipped by -10.36%.

LENSAR Inc's Key Ratios

LENSAR Inc has a market cap of $38.01 million, indicating a price to book ratio of 0.7559 and a price to sales ratio of 0.8956.

In the last 12-months LENSAR Inc’s revenue was $38.24 million with a gross profit of $19.96 million and an EBITDA of $-12431000. The EBITDA ratio measures LENSAR Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, LENSAR Inc’s operating margin was -36.41% while its return on assets stood at -13.4% with a return of equity of -42.71%.

In Q2, LENSAR Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 49.4%.

LENSAR Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.8 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into LENSAR Inc’s profitability.

LENSAR Inc stock is trading at a EV to sales ratio of 0.4355 and a EV to EBITDA ratio of -1.0145. Its price to sales ratio in the trailing 12-months stood at 0.8956.

LENSAR Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$71.20 million
Total Liabilities
$10.56 million
Operating Cash Flow
$0
Capital Expenditure
$181000
Dividend Payout Ratio
0%

LENSAR Inc ended 2024 with $71.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $71.20 million while shareholder equity stood at $32.69 million.

LENSAR Inc ended 2024 with $0 in deferred long-term liabilities, $10.56 million in other current liabilities, 112000.00 in common stock, $-110533000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $25.47 million and cash and short-term investments were $25.47 million. The company’s total short-term debt was $549,000 while long-term debt stood at $0.

LENSAR Inc’s total current assets stands at $49.16 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $3.82 million compared to accounts payable of $4.62 million and inventory worth $18.15 million.

In 2024, LENSAR Inc's operating cash flow was $0 while its capital expenditure stood at $181000.

Comparatively, LENSAR Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$3.03
52-Week High
$6.19
52-Week Low
$1.9
Analyst Target Price
$12

LENSAR Inc stock is currently trading at $3.03 per share. It touched a 52-week high of $6.19 and a 52-week low of $6.19. Analysts tracking the stock have a 12-month average target price of $12.

Its 50-day moving average was $3.49 and 200-day moving average was $3.1 The short ratio stood at 3.15 indicating a short percent outstanding of 0%.

Around 1796.7% of the company’s stock are held by insiders while 4767.6% are held by institutions.

Frequently Asked Questions About LENSAR Inc

The stock symbol (also called stock or share ticker) of LENSAR Inc is LNSR

The IPO of LENSAR Inc took place on 2020-10-02

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
eMudhra Limited (EMUDHRA)
$470
-22.7
-4.61%
BPL Limited (500074)
$69.08
-4.75
-6.43%
$986.85
-39.6
-3.86%
$38.63
-1.69
-4.19%
$94.94
0.36
+0.38%
$737.65
-19.2
-2.54%
$3580.6
101.25
+2.91%
$11.92
-0.24
-1.97%
Viaan Industries Ltd (VIAANINDUS)
$0.65
0.01
+1.56%
$156.6
-7.5
-4.57%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Address

2800 Discovery Drive, Orlando, FL, United States, 32826